Overview

Green Tea Extract in Treating Patients With Nonmetastatic Bladder Cancer

Status:
Completed
Trial end date:
2017-06-09
Target enrollment:
Participant gender:
Summary
Green tea extract contains ingredients that may slow the growth of certain cancers. It is not yet known whether green tea extract is more effective than a placebo when given before surgery in treating patients with bladder. This randomized phase II trial is studying green tea extract to see how well it works compared to a placebo when given before surgery in treating patients with nonmetastatic bladder cancer.
Phase:
Phase 2
Details
Lead Sponsor:
National Cancer Institute (NCI)
Treatments:
Epigallocatechin gallate